Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
44.36
+0.19 (0.43%)
At close: Feb 27, 2026

SHA:688799 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,5161,3991,4031,2731,135
Other Revenue
-14.0629.3319.211.95
1,5161,4131,4331,2931,147
Revenue Growth (YoY)
7.27%-1.39%10.84%12.74%20.61%
Cost of Revenue
-547.62512.15421.91319.33
Gross Profit
1,516865.33920.64870.75827.26
Selling, General & Admin
-547.26595.34595.97585.96
Research & Development
-158.33103.1888.6770.06
Other Operating Expenses
1,27020.317.6816.914.05
Operating Expenses
1,270726.21717.67703.76671.38
Operating Income
245.13139.12202.97166.99155.89
Interest Expense
--0.02---
Interest & Investment Income
-16.8416.0215.215.87
Currency Exchange Gain (Loss)
-0.420.010.53-0.03
Other Non Operating Income (Expenses)
0.42-1.1-0.24-0.24-0.51
EBT Excluding Unusual Items
245.55155.27218.76182.5161.21
Gain (Loss) on Sale of Investments
--24.31---
Gain (Loss) on Sale of Assets
--0.03-0.48-0.89-0.39
Legal Settlements
---5.28--1.95
Other Unusual Items
-30.7516.8713.3621.16
Pretax Income
245.55161.68229.88194.96180.03
Income Tax Expense
4.0822.9236.8421.5719.27
Earnings From Continuing Operations
241.47138.76193.04173.39160.76
Minority Interest in Earnings
-25.5618.289.42-
Net Income
241.47164.32211.32182.8160.76
Net Income to Common
241.47164.32211.32182.8160.76
Net Income Growth
46.95%-22.24%15.60%13.71%10.85%
Shares Outstanding (Basic)
131131131131112
Shares Outstanding (Diluted)
131131131131112
Shares Change (YoY)
-0.17%-0.03%0.19%17.21%13.60%
EPS (Basic)
1.841.251.611.391.44
EPS (Diluted)
1.841.251.611.391.44
EPS Growth
47.20%-22.22%15.38%-2.98%-2.43%
Free Cash Flow
--91.65108.6823.822.63
Free Cash Flow Per Share
--0.700.830.180.20
Dividend Per Share
-0.4290.6430.6430.500
Dividend Growth
--33.33%-28.58%-
Gross Margin
100.00%61.24%64.25%67.36%72.15%
Operating Margin
16.17%9.85%14.17%12.92%13.60%
Profit Margin
15.93%11.63%14.75%14.14%14.02%
Free Cash Flow Margin
--6.49%7.58%1.84%1.97%
EBITDA
314.03208.03263.99215.78190.11
EBITDA Margin
20.72%14.72%18.43%16.69%16.58%
D&A For EBITDA
68.968.961.0248.7934.22
EBIT
245.13139.12202.97166.99155.89
EBIT Margin
16.17%9.85%14.17%12.92%13.60%
Effective Tax Rate
1.66%14.17%16.03%11.06%10.70%
Revenue as Reported
-1,4131,4331,2931,147
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.